Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Michigan for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Michigan only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Michigan (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Scott Sneed (NPI 1740281948)

Field	Value
Entity Type	Individual
Organization	Scott Sneed
Address	860 E Front St
City	Traverse City
State	MI
ZIP	49686
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	August 10, 2005

Payer Source	Total Paid
Medicare	$2.8M
Medicaid	$0

Key Findings

SCOTT SNEED is a retina-focused ophthalmology practice with lifetime Medicare revenue of $2.8M and no Medicaid billing on file, making the provider effectively single-payer (Medicare) in this dataset and limiting payer-mix exposure to non-Medicaid payers. The absence of any Medicaid claims suggests referrals and patient mix are concentrated in Medicare-aged or Medicare-covered populations rather than state-covered lines.

Revenue is highly concentrated in a small set of biologic injection codes: the precomputed top three Medicare codes account for 86.3% of the provider's total Medicare revenue, indicating a procedure-driven practice centered on intravitreal biologic therapy rather than general ophthalmic office visits or diagnostic testing. This concentration implies that anti-VEGF and related intravitreal injections are the primary service line driving the practice’s economics.

The single largest revenue source is J0178 (aflibercept) at $1.3M, representing 45.3% of Medicare revenue and reflecting heavy utilization of aflibercept for retinal disease management. J2778 (ranibizumab) and J2777 (faricimab-svoa) are the next largest, at 24.4% and 16.6% respectively, together with J0178 forming the dominant treatment mix and supporting the interpretation of a retina practice that performs frequent intravitreal injections.

Competitive standing by national rank shows mixed results across the top codes: the provider ranks in the 94th percentile nationally for J2778 (rank #78 of 1208), indicating notably high utilization of ranibizumab compared with peers, while J0178 sits in the 81th percentile (rank #608 of 3204) and J2777 in the 67th percentile (rank #671 of 2039), both described as typical or unremarkable volumes. These percentile positions suggest SCOTT SNEED is a high-volume user of ranibizumab relative to peers but otherwise a modest-to-typical national participant for the other major biologics.

Non-procedure E/M and diagnostic codes are present but contribute much less to revenue: 99214 generates $123.7K (4.5% of Medicare revenue) and ranks as an extreme outlier nationally (99th percentile), indicating unusually high billing volume for moderate-complexity office visits compared with other clinicians. Diagnostic imaging codes such as 92134 and procedure code 67028 also appear but account for single-digit percentages of total revenue, reinforcing that injections are the core revenue driver while evaluations and imaging are secondary.

The provider’s NPI was enumerated on 2005-08-10, which indicates approximately 21 years of Medicare enrollment; this tenure supports an established practice likely experienced in retina procedures and in operating within Medicare reimbursement structures. Long-standing enrollment combined with the concentrated injection mix suggests operational stability focused on intravitreal therapy delivery.

Given the heavy dependence on a few biologic injection codes (86.3% concentrated in the top three), the provider’s financial performance is sensitive to changes in utilization patterns, reimbursement rates, or shifts in drug mix for aflibercept, ranibizumab, and faricimab-svoa. For payers and network planners, this profile signals a specialist whose value proposition centers on procedural retinal care rather than broad ambulatory ophthalmology services.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

15 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	1,830	$690	$1.3M
J2778	Injection, ranibizumab, 0.1 mg	3,720	$180	$676.1K
J2777	Injection, faricimab‑svoa, 0.1 mg	15,900	$30	$461.1K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,630	$90	$149.9K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	1,410	$90	$123.7K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	1,960	$30	$54.9K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	120	$110	$13.5K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	150	$70	$10K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	130	$60	$7.8K
92235	The provider uses a special dye, fluorescein that causes the blood vessels in the one or both eyes to stand out in photographic images taken with the use of multiframe timing, or serial images, taken…	80	$100	$7.3K

Showing 1–10 of 15

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 15 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Michigan Distribution

Scott Sneed — 4 of 15 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Michigan

Full comparison — all codes billed, vs. state median

15 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	17	110	680	$690	$630.2K
J2777	15	60	7,200	$30	$321K
J2778	3	50	730	$180	$240.5K
67028	14	160	440	$90	$57.6K
J3590	63	80	140	$80	$19.6K
92014	435	1,080	100	$80	$14.8K
99214	45	15,470	80	$80	$11.4K
92235	29	100	40	$100	$7.8K
92134	24	820	60	$30	$7.1K
92012	420	460	50	$60	$6.8K

Showing 1–10 of 15

Related Providers

Other providers that share a Tax Identification Number (TIN) with Scott Sneed, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Associated Retinal Consultants, PC	MI	Ophthalmology Physician	$0	$21.1M
Sandeep Randhawa	MI	Retina Specialist (Ophthalmology) Physician	$7M	$0
Scott Pendergast	OH	Retina Specialist (Ophthalmology) Physician	$6M	$0
Ramon Lee	IL	Retina Specialist (Ophthalmology) Physician	$4M	$8.5K
Jeremy Wolfe	MI	Retina Specialist (Ophthalmology) Physician	$3.7M	$0
Christianne Wa	CA	Retina Specialist (Ophthalmology) Physician	$3.5M	$0
Douglas Covert	MI	Retina Specialist (Ophthalmology) Physician	$3.2M	$0
Nathan Farley	MI	Retina Specialist (Ophthalmology) Physician	$3M	$0
Tamer Mahmoud	MI	Retina Specialist (Ophthalmology) Physician	$2.8M	$0
George Williams	MI	Retina Specialist (Ophthalmology) Physician	$2.7M	$0

Nearby Providers

Other providers in the same ZIP code as Scott Sneed, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Autism Center Of Northern Michigan	MI	Community/Behavioral Health Agency	$0	$19M
Jonathan Timm	MI	Behavior Analyst	$0	$6.2M
North Arrow Aba, LLC	MI	Behavior Analyst	$0	$5.8M
Diane Fiander	MI	Retina Specialist (Ophthalmology) Physician	$2.2M	$0
North Flight Aero Med	MI	Air Ambulance	$772.9K	$716.6K
John Mcmanus	MI	Ophthalmology Physician	$290.4K	$0
Mark Pomaranski	MI	MOHS-Micrographic Surgery Physician	$273K	$0
Brian Heeringa	MI	Surgery Physician	$153.4K	$0
Paula Cahill	MI	Dermatology Physician	$142.6K	$0
Peter Fedor	MI	Ophthalmology Physician	$136.5K	$0

Scott Sneed — Billing Profile & Reimbursement Data

Sign up for Scott Sneed — Billing Profile & Reimbursement Data policy alerts

Scott Sneed — Billing Profile & Reimbursement Data

Sign up for Scott Sneed — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References